The SBV515 Dye from Bio-Rad improves brightness to enhance its use in flow cytometry.
The StarBright Violet 515 (SBV515) Dye, a range of fluorescent nanoparticles from Bio-Rad Laboratories, can enhance flow cytometry. With an excitation maximum at 401 nanometers and emission maximum of 516 nanometers, the dye improves brightness to solve rare and low antigen density populations. In addition, its narrow emission profile reduces spillover onto other filters and allows only minimal excitation by other lasers.
The dye is not vulnerable to photobleaching, distributes high lot-to-lot reproducibility, and is stable at 4° C with no loss of signal. There is also no requirement to use a special staining buffer, which allows for integration into common experimental protocols without compromising performance.
“StarBright Violet 515 Dye is brighter than other common dyes that emit at similar wavelengths,” said Mike Blundell, Bio-Rad product manager, Life Science Group, in a Sept. 14, 2020 press release. “The dye is flexible enough to fit into any flow cytometry panel, allowing researchers to multiplex with ease regardless of flow cytometer and experimental protocol, and it offers a superior alternative for fluorophores that have emission maxima between 500 and 550 nanometers.”
Source: Bio-Rad
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.